Title: “Advancing Genomic Discoveries & Implementation: A focus on Underrepresented groups"
Seminar in Precision Medicine series, co-presented by the Center for Precision Medicine and Genomics, the Columbia Precision Medicine Initiative, and the Precision Medicine Resource of the Irving Institute for Clinical and Translational Research. This event is supported in part by a gift from Pfizer to Columbia.
Speaker: Nita A. Limdi, Pharm.D, Ph.D, MSPH, FAHA
Professor Department of Neurology & Epidemiology ; Director, Translational Pharmacogenomics Program; Associate Director, Hugh Kaul Precision Medicine Institute; Co-Director, CTSA Training Academy
With a focus on Drug therapy for Chronic Diseases, Limdi will present how observations at the bedside (as a clinical pharmacist) led her to the bench (research - epidemiologist) to study predictors (including genomics) of drug response.
Over 2 decades, her work has shed light on understanding variability in anticoagulant response in diverse populations - highlighting the influence of genes, comorbid conditions… and the importance of deep clinical phenotyping and robust study design and letting the data drive further exploration
A leader in pharmacogenomics consortia – she has collaborated extensively in evidence reviews and guideline development
Bringing this back to the bedside, she leads implementation of pharmacogenomics at UABHS and will be presenting some of this work
Finally, she will present UAB’s effort and collaborations in eMERGE, developing and returning polygenic risk scores for 10 conditions in a diverse in primary care population
Zoom and in-person. Please register to receive the Zoom link for the event.
Refreshments will be served!